Proteomics in discovery of hepatocellular carcinoma biomarkers

被引:0
|
作者
Wu Cheng [1 ]
Li Song-Tao [2 ]
Liu Li-Jie [1 ]
Wang Zhan-Feng
Lu Jun-Hua [3 ]
Liu Bao-Hai [1 ]
Liao Ping [4 ]
Wang Wen-Jing [4 ]
Zhu Liang [1 ]
机构
[1] Second Mil Med Univ, Dept Gastroenterol, Affiliated Hosp 2, Shanghai 200043, Peoples R China
[2] Second Mil Med Univ, Dept Surg, Eastern Hepatobiliary Surg Hosp, Shanghai 200043, Peoples R China
[3] China Sci & Technol Univ, Dept Stat & Finance, Beijing, Peoples R China
[4] Shanghai Municipal Ctr, Dept Publ Hlth & Mol Biol, Shanghai, Peoples R China
关键词
proteomics; biomarker; hepatocellular carcinoma;
D O I
10.1007/s11670-007-0159-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To discover new proteomic biomarkers of hepatocellular carcinoma. Methods: Surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry was used to discover biomarkers for differentiating hepatocellular carcinoma and chronic liver disease. A population of 50 patients with hepatocellular carcinoma and 33 patients with chronic liver disease was studied. Results: Twelve proteomic biomarkers of hepatocellular carcinoma were detected in this study. Three proteomic biomarkers were highly expressed in hepatocellular carcinoma and nine proteomic biomarkers were highly expressed in chronic liver disease. The most valuable proteomic biomarker with m/z=11498 had no similar diagnostic value as alpha-fetoprotein. Conclusion: Some of the twelve proteomic biomarkers may become new biomarkers of hepatocellular carcinoma.
引用
收藏
页码:159 / 164
页数:6
相关论文
共 50 条
  • [21] Biomarkers for hepatocellular carcinoma
    Goshi Shiota
    Norimasa Miura
    Clinical Journal of Gastroenterology, 2012, 5 (3) : 177 - 182
  • [22] Biomarkers for Hepatocellular Carcinoma
    Behne, Tara
    Copur, M. Sitki
    INTERNATIONAL JOURNAL OF HEPATOLOGY, 2012, 2012
  • [23] Biomarkers for hepatocellular carcinoma
    Shiota, Goshi
    Miura, Norimasa
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2012, 5 (03) : 177 - 182
  • [24] Biomarkers for Hepatocellular Carcinoma
    Roberts, Lewis R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (04) : 223 - 226
  • [25] Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients
    Mustafa, Gul M.
    Larry, Denner
    Petersen, John R.
    Elferink, Cornelis J.
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (10) : 1312 - 1324
  • [26] Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients
    Gul M Mustafa
    Denner Larry
    John R Petersen
    Cornelis J Elferink
    World Journal of Hepatology, 2015, 7 (10) : 1312 - 1324
  • [27] Proteomics for discovery of candidate colorectal cancer biomarkers
    Paula lvarez-Chaver
    Olalla Otero-Estévez
    María Páez de la Cadena
    Francisco J Rodríguez-Berrocal
    Vicenta S Martínez-Zorzano
    World Journal of Gastroenterology, 2014, 20 (14) : 3804 - 3824
  • [28] Proteomics for discovery of candidate colorectal cancer biomarkers
    Alvarez-Chaver, Paula
    Otero-Estevez, Olalla
    Paez de la Cadena, Maria
    Rodriguez-Berrocal, Francisco J.
    Martinez-Zorzano, Vicenta S.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (14) : 3804 - 3824
  • [29] Comparative analysis of tissue proteomes for the discovery of biomarkers for high risk of hepatocellular carcinoma
    Yim, D. -J.
    Lee, E. -Y.
    Lee, J. -A.
    Paik, Y. -K.
    Wang, H. -J.
    Cheong, J. -Y.
    Cho, S. -W.
    Hahm, K. -B.
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) : S164 - S164
  • [30] Proteomics discovery of radioresistant cancer biomarkers for radiotherapy
    Chang, Lei
    Graham, Peter
    Hao, Jingli
    Bucci, Joseph
    Malouf, David
    Gillatt, David
    Li, Yong
    CANCER LETTERS, 2015, 369 (02) : 289 - 297